Ben Beneski in

Ben Beneski

Login to view DISC.
Chief Technical Officer (CTO) at Allogene Therapeutics
📍 San Francisco, California, United States

Ben Beneski is the Chief Technical Officer at Allogene Therapeutics, leveraging over two decades of experience in biologics manufacturing from roles at Amgen and Vir Biotechnology. Educated at Stevens Institute of Technology and Northeastern, he focuses on advancing the companys pioneering allogeneic cell therapy programs through technical and operational leadership.

Outside of work, Ben is passionate about connecting his team to the community they serve. He leads and participates in volunteer activities, such as serving dinner at Family House, to create a direct and meaningful connection with patients and their families, reinforcing the human impact of their scientific work.

Ben led the design, construction, and startup of Cell Forge 1, Allogenes state-of-the-art cell therapy manufacturing facility.

Read the full overview →
Experience
16 Years
Current Role
Chief Technical Officer (CTO)
Job Level
Leadership
Location
San Francisco, California, United States
Personality Overview

How Ben shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Ben cares about

Cell Therapy Manufacturing
He is a frequent speaker on advancing cell therapy manufacturing and is focused on solving challenges to achieve commercial viability and greater scale.
Biomanufacturing Innovation
As CTO with deep experience in CMC operations, he is focused on creating innovative solutions and next-generation platforms for biomanufacturing.
+5 more topics Login to view topics
Career

Work history

3-2025
Chief Technical Officer (CTO)
Allogene Therapeutics
5-2024 - 3-2025
Vice President, Product Development and Manufacturing
Allogene Therapeutics
2-2022 - 5-2024
Vice President, Manufacturing
Allogene Therapeutics
5-2018 - 5-2019
Sr. Director, CMC Lifecycle Operations
Vir Biotechnology, Inc.
11-2013 - 5-2018
Director Global Operations
Amgen
In the press

Media appearances

Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief .... Featured in Allogene Therapeutics Investor Relations
See now
Education
2001 - 2003
MBA
D'Amore-McKim School of Business at Northeastern University
1994 - 1998
BE
Stevens Institute of Technology
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Ben. Free, 10 seconds.